These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12744865)

  • 21. Influenza vaccine oculorespiratory syndrome incidence is reduced in HIV.
    Cooper C; Thorne A;
    Vaccine; 2011 Oct; 29(45):7876-7. PubMed ID: 21872629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Necrotizing glomerulonephritis in decursu vasculitis after vaccination against influenza].
    Hyla-Klekot L; Kucharska G; Cieslak W
    Pol Merkur Lekarski; 2005 Jul; 19(109):75-7. PubMed ID: 16194032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries.
    Haugh M; Gresset-Bourgeois V; Macabeo B; Woods A; Samson SI
    Expert Rev Vaccines; 2017 Jun; 16(6):545-564. PubMed ID: 28460594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compatibility of ASO3-adjuvanted H1N1pdm09 and seasonal trivalent influenza vaccines in adults: results of a randomized, controlled trial.
    Scheifele DW; Ward BJ; Dionne M; Vanderkooi OG; Loeb M; Coleman BL; Li Y;
    Vaccine; 2012 Jul; 30(32):4728-32. PubMed ID: 22652402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oculo-respiratory syndrome in association with the influenza vaccine: Canada, October-November 2000.
    Can Commun Dis Rep; 2000 Dec; 26(23):201-2. PubMed ID: 11149349
    [No Abstract]   [Full Text] [Related]  

  • 26. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
    Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
    Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial.
    Sharma S; Singh VB; Kumar S; Prajapati V; Patel J; Vukkala R; Jangid SK; Sanmukhani J; Gupta G; Patel P; Mittal R; Glueck R
    Hum Vaccin Immunother; 2018 Jun; 14(6):1362-1369. PubMed ID: 29461913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip) to adults aged ≥60 years: an open-label, randomised trial.
    Zimmermann U; Gavazzi G; Richard P; Eymin C; Soubeyrand B; Baudin M
    Vaccine; 2013 Mar; 31(11):1496-502. PubMed ID: 23313654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fever following administration of two inactivated influenza vaccines--a survey of parents of New Zealand infants and children 5 years of age and under.
    Petousis-Harris H; Poole T; Booy R; Turner N
    Vaccine; 2011 Apr; 29(16):2933-7. PubMed ID: 21338679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: the importance of routine active safety surveillance.
    Petousis-Harris H; Poole T; Turner N; Reynolds G
    Vaccine; 2012 Jul; 30(33):4945-52. PubMed ID: 22664224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggregate content influences the Th1/Th2 immune response to influenza vaccine: evidence from a mouse model.
    Babiuk S; Skowronski DM; De Serres G; HayGlass K; Brunham RC; Babiuk L
    J Med Virol; 2004 Jan; 72(1):138-42. PubMed ID: 14635022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine.
    Schmidt MA; Crane B; Mullooly JP; Naleway AL
    Vaccine; 2010 Nov; 28(49):7713-5. PubMed ID: 20875495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza vaccination in adults with asthma: safety of an inactivated trivalent influenza vaccine.
    Kmiecik T; Arnoux S; Kobryn A; Gorski P
    J Asthma; 2007 Dec; 44(10):817-22. PubMed ID: 18097856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec, Canada.
    Rouleau I; De Serres G; Skowronski DM; Drolet JP; Lemire C; Toth E; Landry M
    Vaccine; 2014 Jun; 32(28):3480-7. PubMed ID: 24793951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Short communication: Evaluation of the flu vaccine administered to health care workers in Trakya University Hospital in 2006].
    Kuloğlu F; Celik' AD; Yuluğkural Z; Erkan T; Keskin S; Akata F
    Mikrobiyol Bul; 2008 Jan; 42(1):137-42. PubMed ID: 18444572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trivalent inactivated influenza vaccine safety in children: assessing the contribution of telephone encounters.
    Mullooly JP; Crane B; Chun C
    Vaccine; 2006 Mar; 24(13):2256-63. PubMed ID: 16375995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seasonal influenza vaccines.
    Fiore AE; Bridges CB; Cox NJ
    Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events.
    Dey A; Gidding HF; Menzies R; McIntyre P
    Vaccine; 2014 Apr; 32(19):2204-8. PubMed ID: 24613527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events.
    Kharbanda EO; Vazquez-Benitez G; Lipkind H; Naleway A; Lee G; Nordin JD;
    Obstet Gynecol; 2013 Sep; 122(3):659-67. PubMed ID: 23921876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and safety of pandemic influenza A (H1N1) 2009 vaccine in healthcare workers at a university hospital in Japan.
    Igari H; Watanabe A; Chiba H; Shoji K; Segawa S; Nakamura Y; Watanabe M; Suzuki K; Sato T
    Jpn J Infect Dis; 2011; 64(3):177-82. PubMed ID: 21617299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.